Nabiximols (Sativex): A Breakthrough in Cannabis-Based Medicine
Nabiximols, marketed under the brand name Sativex, is a pioneering cannabis-based medication developed by GW Pharmaceuticals in the United Kingdom. It is an oromucosal spray designed to alleviate symptoms associated with multiple sclerosis (MS), including neuropathic pain, spasticity, and overactive bladder. Composition and Administration Nabiximols is a standardized combination of two primary cannabinoids: • Tetrahydrocannabinol …
Nabiximols (Sativex): A Breakthrough in Cannabis-Based Medicine Read More »